SI-BONE, Inc. — Director's Dealing 2020

Dec 18, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2020-12-16

Reporting Person: RECUPERO ANTHONY J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-16	Common Stock	M	3000.00	$4.32	Acquired	71882.00	Direct
2020-12-16	Common Stock	S	1872.00	$29.2896	Disposed	70010.00	Direct
2020-12-16	Common Stock	S	200.00	$27.90	Disposed	69810.00	Direct
2020-12-16	Common Stock	S	928.00	$29.8821	Disposed	68882.00	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-16	Stock Option (Right to Buy)	$4.32	M	3000.00	Disposed	2026-07-26	Common Stock (3000.00)	Direct

Footnotes

F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $28.72 to $29.69, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F3: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $27.72 to $28.08, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F4: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $29.72 to $30.15, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F5: Includes 57,057 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

F6: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.